Related references
Note: Only part of the references are listed.Interferon (IFN)-γ-inducible protein-10:: Association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-α2a and ribavirin for chronic hepatitis C virus infection
Ana I. Romero et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Association of pretreatment serum interferon γ inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C
M Diago et al.
GUT (2006)
Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection
I Bièche et al.
VIROLOGY (2005)
Global epidemiology of hepatitis C virus infection
CW Shepard et al.
LANCET INFECTIOUS DISEASES (2005)
Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation
KJ Helbig et al.
HEPATOLOGY (2004)
Cross-genotype immunity to hepatitis C virus
RE Lanford et al.
JOURNAL OF VIROLOGY (2004)
The natural history of hepatitis C
NH Afdhal
SEMINARS IN LIVER DISEASE (2004)
Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation
CE Harvey et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Progression of fibrosis in chronic hepatitis C
MG Ghany et al.
GASTROENTEROLOGY (2003)
Progression of fibrosis in untreated patients with hepatitis C virus infection
LM Lagging et al.
LIVER (2002)
Hepatitis activity index is a key factor in determining the natural history of chronic hepatitis C
H Fontaine et al.
HUMAN PATHOLOGY (2001)
DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection
CB Bigger et al.
JOURNAL OF VIROLOGY (2001)
Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C
T Poynard et al.
JOURNAL OF HEPATOLOGY (2001)
Share Paper
